Literature DB >> 24217922

Therapeutic effects of suppressors of cytokine signaling in diabetic nephropathy.

Qingjuan Liu1, Lingling Xing, Lei Wang, Fang Yao, Shuxia Liu, Jun Hao, Wei Liu, Huijun Duan.   

Abstract

Inflammation is an important pathophysiological mechanism in diabetic nephropathy (DN). Tubular epithelial cell-myofibroblast transdifferentiation (TEMT), which can be induced by many cytokines, is an important event in DN. Oncostatin M (OSM), an inflammatory cytokine, can induce TEMT in vitro. The suppressors of cytokine signaling (SOCS) proteins are negative-feedback regulators of cytokine signaling. The purpose of this study was to investigate the role of SOCS in DN. The results demonstrated that overexpression of SOCS ameliorated proteinuria, the expression of α-SMA and OSM in tubular epithelial cells, and interstitial extracellular matrix accumulation in the renal tissue of CD-1 mice. In addition, our previous studies indicated that OSM induced TEMT by activating the JAK/STAT pathway, which could be inhibited by SOCS. These results indicate that overexpression of SOCS has a therapeutic effect in DN.

Entities:  

Keywords:  SOCS; diabetic nephropathy; epithelial-myofibroblast transdifferentiation; oncostatin M

Mesh:

Substances:

Year:  2013        PMID: 24217922      PMCID: PMC3902095          DOI: 10.1369/0022155413512493

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  33 in total

1.  Interleukin-1 induces tubular epithelial-myofibroblast transdifferentiation through a transforming growth factor-beta1-dependent mechanism in vitro.

Authors:  J M Fan; X R Huang; Y Y Ng; D J Nikolic-Paterson; W Mu; R C Atkins; H Y Lan
Journal:  Am J Kidney Dis       Date:  2001-04       Impact factor: 8.860

2.  Tubular injury in glomerular disease.

Authors:  Timothy W Meyer
Journal:  Kidney Int       Date:  2003-02       Impact factor: 10.612

3.  Interstitial expression of alpha-SMA: an early marker of chronic renal allograft dysfunction.

Authors:  Chérif Badid; Alexis Desmouliere; Daniela Babici; Aoumeur Hadj-Aissa; Brigitte McGregor; Nicole Lefrancois; Jean Louis Touraine; Maurice Laville
Journal:  Nephrol Dial Transplant       Date:  2002-11       Impact factor: 5.992

4.  Evidence that fibroblasts derive from epithelium during tissue fibrosis.

Authors:  Masayuki Iwano; David Plieth; Theodore M Danoff; Chengsen Xue; Hirokazu Okada; Eric G Neilson
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

5.  SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2.

Authors:  Liangyou Rui; Minsheng Yuan; Daniel Frantz; Steven Shoelson; Morris F White
Journal:  J Biol Chem       Date:  2002-09-12       Impact factor: 5.157

6.  Significance of tubulointerstitial changes in the renal cortex for the excretory function and concentration ability of the kidney: a morphometric contribution.

Authors:  A Bohle; S Mackensen-Haen; H von Gise
Journal:  Am J Nephrol       Date:  1987       Impact factor: 3.754

Review 7.  Tubulo-interstitial changes in glomerulopathy. II. Prognostic significance.

Authors:  Krzysztof Okoń
Journal:  Pol J Pathol       Date:  2003       Impact factor: 1.072

8.  Suppressors of cytokine signaling regulate Fc receptor signaling and cell activation during immune renal injury.

Authors:  Carmen Gómez-Guerrero; Oscar López-Franco; Guillermo Sanjuán; Purificación Hernández-Vargas; Yusuke Suzuki; Guadalupe Ortiz-Muñoz; Julia Blanco; Jesús Egido
Journal:  J Immunol       Date:  2004-06-01       Impact factor: 5.422

9.  Oncostatin M, a cytokine released by activated mononuclear cells, induces epithelial cell-myofibroblast transdifferentiation via Jak/Stat pathway activation.

Authors:  Joanna Nightingale; Sharmila Patel; Naotaka Suzuki; Roger Buxton; Ken-ichro Takagi; Jun Suzuki; Yoshihiko Sumi; Atsushi Imaizumi; Roger M Mason; Zhi Zhang
Journal:  J Am Soc Nephrol       Date:  2004-01       Impact factor: 10.121

Review 10.  Inflammation in diabetic nephropathy.

Authors:  Andy K H Lim; Gregory H Tesch
Journal:  Mediators Inflamm       Date:  2012-08-21       Impact factor: 4.711

View more
  9 in total

1.  Suppressor of Cytokine Signaling-1 Peptidomimetic Limits Progression of Diabetic Nephropathy.

Authors:  Carlota Recio; Iolanda Lazaro; Ainhoa Oguiza; Laura Lopez-Sanz; Susana Bernal; Julia Blanco; Jesus Egido; Carmen Gomez-Guerrero
Journal:  J Am Soc Nephrol       Date:  2016-09-08       Impact factor: 10.121

2.  Role of TGF-β1/p38 MAPK pathway in hepatitis B virus-induced tubular epithelial-myofibroblast transdifferentiation.

Authors:  Changhong Liu; Fengzhe Chen; Xiaochun Han; Hui Xu; Yiguo Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

Review 3.  JAK inhibition and progressive kidney disease.

Authors:  Frank C Brosius; John Cijiang He
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-01       Impact factor: 2.894

4.  HMGB1 is activated in type 2 diabetes mellitus patients and in mesangial cells in response to high glucose.

Authors:  Yan Chen; Fengli Qiao; Ying Zhao; Yanjun Wang; Guifeng Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

5.  Exploring the mechanisms underlying the therapeutic effect of Salvia miltiorrhiza in diabetic nephropathy using network pharmacology and molecular docking.

Authors:  Lili Zhang; Lin Han; Xinmiao Wang; Yu Wei; Jinghui Zheng; Linhua Zhao; Xiaolin Tong
Journal:  Biosci Rep       Date:  2021-06-25       Impact factor: 3.840

6.  Protective effects of SOCS3 overexpression in high glucose‑induced lung epithelial cell injury through the JAK2/STAT3 pathway.

Authors:  Wei-Na Duan; Zhong-Yuan Xia; Min Liu; Qian Sun; Shao-Qing Lei; Xiao-Jing Wu; Qing-Tao Meng; Yan Leng
Journal:  Mol Med Rep       Date:  2017-07-06       Impact factor: 2.952

7.  Anti-OSM Antibody Inhibits Tubulointerstitial Lesion in a Murine Model of Lupus Nephritis.

Authors:  Qingjuan Liu; Yunxia Du; Kejun Li; Wei Zhang; Xiaojuan Feng; Jun Hao; Hongbo Li; Shuxia Liu
Journal:  Mediators Inflamm       Date:  2017-05-24       Impact factor: 4.711

8.  T2DiACoD: A Gene Atlas of Type 2 Diabetes Mellitus Associated Complex Disorders.

Authors:  Jyoti Rani; Inna Mittal; Atreyi Pramanik; Namita Singh; Namita Dube; Smriti Sharma; Bhanwar Lal Puniya; Muthukurussi Varieth Raghunandanan; Ahmed Mobeen; Srinivasan Ramachandran
Journal:  Sci Rep       Date:  2017-07-31       Impact factor: 4.379

Review 9.  Targeting Canonical and Non-Canonical STAT Signaling Pathways in Renal Diseases.

Authors:  Lili Gai; Yuting Zhu; Chun Zhang; Xianfang Meng
Journal:  Cells       Date:  2021-06-27       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.